1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Lip Diseases: new trials by email Literature Review of Lip Diseases trials Research Report on Lip Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma Durvalumab, Carboplatin, Nab-paclitaxel - Carcinoma, Squamous Cell, Oral Cancer | Phase 2 | Active not recruiting | UNC Lineberger Comprehensive Cancer Center | 39 | 2017-12-19 | 2026-02-23 |
Carcinoma, Squamous Cell (1) · Esophageal Neoplasms (1) · Laryngeal Neoplasms (1) · Lip Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Laryngeal Diseases (1) · Mouth Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Squamous Cell (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Carboplatin (1) · Cisplatin (1) · Radiotherapy, Intensity-Modulated (1) · durvalumab (1)
UNC Lineberger Comprehensive Cancer Center (1)
United States (1)
Jared Weiss, MD (1)